NewsRoom Articles - Page 1330 of 1443

TuesdayMar 14, 2017 10:30 am

Vascular Biogenics Ltd. (NASDAQ: VBLT) Starts Presentation at 29th Annual Roth Conference

Vascular Biogenics (NASDAQ: VBLT), operating as VBL Therapeutics, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. The company’s lead oncology product candidate, ofranergene obadenovec (VB-111), is a first-in-class, targeted anti-cancer gene-therapy agent that is positioned to treat a wide range of solid tumors. It is conveniently administered as an IV infusion once every two months. It has been observed to be well-tolerated in >200 cancer patients and we have observed its efficacy signals in an “all comers” phase 1 trial as well as in three tumor-specific phase 2 studies. Ofranergene obadenovec…

TuesdayMar 14, 2017 10:30 am

Insperity, Inc. (NYSE: NSP) Starts Presentation at 29th Annual ROTH Conference

Insperity (NYSE: NSP) provides an array of human resources and business solutions designed to help improve business performance. Insperity® Business Performance Advisors offers a comprehensive suite of products and services. The company delivers administrative relief, better benefits, reduced liabilities and a systematic way to improve productivity through its premier Workforce Optimization® solution. Additional company offerings include human capital management, payroll software, time and attendance, performance management, organizational planning, recruiting services, employment screening, financial services, expense management, retirement services and insurance services. For more information, visit the company’s website at www.insperity.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

TuesdayMar 14, 2017 10:30 am

vTv Therapeutics, Inc. (NASDAQ: VTVT) Starts Presentation at 29th Annual Roth Conference

vTv Therapeutics (NASDAQ: VTVT) is a clinical-stage biopharmaceutical company that discovers, develops and sells orally administered small molecule drug candidates worldwide. The company’s drug candidate for the treatment of Alzheimer’s disease comprise azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation end-products, which is in Phase III clinical trials. Its Type 2 diabetes drug candidates include TTP399, an orally administered, liver-selective glucokinase activator that has been completed phase IIb clinical trials; and TTP273, an orally administered, non-peptide agonist that targets the glucagon-like peptide-1 receptor, which is in phase II clinical trials. For more information, visit…

TuesdayMar 14, 2017 10:30 am

Nemaska Lithium, Inc. (NMKEF) Starts Presentation at 29th Annual Roth Conference

Nemaska Lithium (OTC: NMX) engages in the exploration and evaluation of hard rock lithium mining properties and related processing of spodumene into lithium compounds in Canada. The company owns 100% interests in the Whabouchi Property that consists of 33 claims covering an area of 1,716 hectares located in the Eeyou Istchee/James Bay area of Quebec province; and the Sirmac Property, which comprises 24 mining claims covering an area of 1,101 hectares located to the northwest of the town of Chibougamau and southeast of the town of Nemaskain Quebec province. For more information, visit the company’s website at www.nemaskalithium.com. About NetworkNewsWire…

TuesdayMar 14, 2017 10:30 am

Blue Bird Corp. (NASDAQ: BLBD) Starts Presentation at 29th Annual ROTH Conference

Blue Bird (NASDAQ: BLBD) is an independent designer and manufacturer of school buses, with more than 550,000 buses sold since its formation in 1927 and approximately 180,000 buses in operation today. Blue Bird focuses on the design, engineering, manufacture and sale of school buses and related parts. The company is the only manufacturer of chassis and body production specifically designed for school bus applications, and offers alternative fuel applications with its propane-powered and compressed natural gas-powered school buses. Blue Bird manufactures school buses at two facilities in Fort Valley, Georgia. Its Micro Bird joint venture operates a manufacturing facility in…

TuesdayMar 14, 2017 10:00 am

Research Frontiers Inc. (NASDAQ: REFR) Starts Presentation at 29th Annual Roth Conference

Research Frontiers (NASDAQ: REFR) develops and markets the technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device (SPD-Smart) light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, lamination services, and electronics to power end-products incorporating the film, as well as the end-products, such as windows, skylights, and sunroofs. Its SPD-Smart light-control technology is used in multiple product applications. For more information, visit the company’s website at www.smartglass.com. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayMar 14, 2017 10:00 am

Data I/O Corp. (NASDAQ: DAIO) Starts Presentation at 29th Annual ROTH Conference

Data I/O (NASDAQ: DAIO) is a tech company that designs, manufactures and sells programming systems for electronic device manufacturers worldwide. The company’s programming system products are used to program integrated circuits (ICs) with the specific data necessary for the ICs. The company also offers non-automated programming systems comprising FlashPAK III programmer; and Sprint/Unifamily programmers, an off-line, low volume, and engineering non-automated system. For more information, visit the company’s website at www.dataio.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with…

TuesdayMar 14, 2017 10:00 am

Turtle Beach Corp. (NASDAQ: HEAR) Starts Presentation at 29th Annual Roth Conference

Turtle Beach (NASDAQ: HEAR) is an audio technology company that develops, commercializes and markets audio technologies under the Turtle Beach and HyperSound brands in the United States, the United Kingdom, Europe and internationally. It offers headset solutions for use across multiple platforms, including video game and entertainment consoles, handheld consoles, personal computers, tablets and mobile devices. The company provides audio products for commercial and consumers markets, as well as for listeners with hearing loss. The company was formerly known as Parametric Sound Corporation and changed its name to Turtle Beach Corporation in May 2014. For more information, visit the company’s…

TuesdayMar 14, 2017 10:00 am

OTC Markets Group, Inc. (OTCM) Starts Presentation at 29th Annual Roth Conference

OTC Markets Group (OTCQX: OTCM) operates financial markets for U.S. and global securities. The company offers OTC Link ATS that directly links a network of broker-dealers that provides liquidity and execution services for a spectrum of securities; OTC Dealer application that offers broker-dealers an interface into OTC Link ATS; and Fixie, a real-time FIX protocol that allows electronic submission and receipt of quotes, trade messages, and drop copy confirmations. It also provides Market Data Licensing business line provides investors, traders, institutions, and regulators with a suite of enterprise and user market data licenses through direct or extranet connectivity, as well…

TuesdayMar 14, 2017 10:00 am

Checkpoint Therapeutics, Inc. (CKPT) Starts Presentation at 29th Annual ROTH Conference

Checkpoint Therapeutics (OTCQX: CKPT) is an immuno-oncology biopharmaceutical company focused on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company develops a portfolio of human immuno-oncology targeted antibodies. Its products pipeline includes Anti-PD-L1, a preclinical human antagonistic antibody designed to bind to PD-L1 and block its interaction with programmed cell death protein 1; and Anti-GITR, a human agonistic antibody that binds and triggers signaling in glucocorticoid-induced TNFR related protein expressing cells. The company is also developing CK-101, an oral covalent inhibitor, which is in preclinical stage for the treatment of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Vascular Biogenics Ltd. (NASDAQ: VBLT) Starts Presentation at 29th Annual Roth Conference

Insperity, Inc. (NYSE: NSP) Starts Presentation at 29th Annual ROTH Conference

vTv Therapeutics, Inc. (NASDAQ: VTVT) Starts Presentation at 29th Annual Roth Conference

Nemaska Lithium, Inc. (NMKEF) Starts Presentation at 29th Annual Roth Conference

Blue Bird Corp. (NASDAQ: BLBD) Starts Presentation at 29th Annual ROTH Conference

Research Frontiers Inc. (NASDAQ: REFR) Starts Presentation at 29th Annual Roth Conference

Data I/O Corp. (NASDAQ: DAIO) Starts Presentation at 29th Annual ROTH Conference

Turtle Beach Corp. (NASDAQ: HEAR) Starts Presentation at 29th Annual Roth Conference

OTC Markets Group, Inc. (OTCM) Starts Presentation at 29th Annual Roth Conference

Checkpoint Therapeutics, Inc. (CKPT) Starts Presentation at 29th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search